Despite the normal 1:1 ratio formation between METTL3 and METTL14 in healthy cells, gene mutations, abnormal regulation, or changes in environmental factors during the tumor development process may disrupt this balance, resulting in differences in their expression and function. This evidence concerns the gene METTL3 and neoplasm.